Form D · Biotechnology
Kineta Holdings II, LLC
Seattle, WA · CIK 0001579071
Offering snapshot reported Jan 13, 2015 · SEC filing
- Reported sold
- $1.37M Indefinite offering
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Dec 31, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 13, 2015 | Initial | $1,374,400 | No comparison | 26 | SEC filing |
| Jun 12, 2013 | Initial | $751,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-232095
The total amount sold includes offers and sales prior to 12/31/2014 that are potentially integrated for purposes of the exemptions under Regulation D.
Source: Form D, filed Jan 13, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles L. Magness | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
219 Terry Avenue North, Suite 300
Seattle, WA, 98109
Seattle, WA, 98109